Command Palette

Search for a command to run...

smruthi-organics

131.25+4.37%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

In the Pharmaceuticals & Drugs sector, Smruthi Organics Ltd. significantly underperforms compared to its peers, showing zero growth and profitability metrics. In contrast, companies like Sun Pharmaceutical and Cipla demonstrate strong growth, solid profitability, and attractive valuations, making them sector leaders. Smruthi's financials indicate it is a potential value trap, requiring careful consideration by investors.

Key Points
  • Smruthi Organics Ltd. shows no revenue growth and zero profitability metrics.
  • Sun Pharmaceutical Industries and Cipla lead in profitability and growth with high ROE and EPS.
  • Dr. Reddy's Laboratories and Mankind Pharma are strong performers with robust revenue growth and efficient operations.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest revenue growth (YoY: 8.42%) and strong profitability (ROE: 16.13%, EPS: 45.55).

Cipla Ltd.

Strong growth (YoY: 13.28%) with solid profitability metrics (ROE: 16.63%, PE: 23.73).

Dr. Reddy's Laboratories Ltd.

Consistent growth (YoY: 16.54%) with attractive valuation (PE: 15.50) and high ROE (21.76).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.